-
Also late yesterday, Boston Scientific (BSX) said the U.S. Food and Drug Administration has approved its latest drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.
FORBES: Health Care News: Merck, Boston Scientific
-
The new Abbott also sells medical devices such as artery-clearing drug-eluting Xience stent or its absorbable stent known as Absorb and diagnostic tests used in laboratories and hospitals such as its Architect platform.
FORBES: Move up http://i.forbesimg.com t Move down
-
In the vascular business, the company is developing a next-generation Drug Eluting Stent, XIENCE Xpedition, which is expected to launch in Europe this year and in the U.S. in 2013.
FORBES: Abbott Labs Snapshot As AbbVie Begins Trading
-
Moderate growth is expected from vascular and diagnostics division (excluding to certain royalty and supply arrangement revenues and currency impact), after the company launched various products including its next-generation Drug Eluting Stent XIENCE Xpedition and XIENCE PRIME in different parts of the world.
FORBES: Abbott Earnings Preview: What We Are Watching